Inverse VIX Short-Term Futures ETNs due March 22, 2045 financials
$31.16−0.11%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $280.35B |
| Gross profit | $182.45B |
| Gross margin | 65.1% |
| Operating income | $72.59B |
| Net income | $55.68B |
| Net margin | 19.9% |
| Diluted EPS | $20.02 |
| EBITDA | $72.59B |
| Operating cash flow | -$147.78B |
| Free cash flow | -$147.78B |
| Diluted shares | 2,781.5M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $21.74B |
| Short-term investments | $2.52T |
| Total debt | $499.98B |
| Total assets | $4.42T |
| Total liabilities | $4.06T |
| Shareholders' equity | $362.44B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology